Celltheon Unveils a New Era in Biomanufacturing
Celltheon has made a significant stride in biomanufacturing technology with the launch of its OmniCHO™ Transient Expression Kit. This innovative kit is based on CHO-K1 cell lines and is engineered to redefine the landscape of preclinical drug development. By simplifying complex processes, Celltheon is helping researchers streamline their efforts and focus on breakthroughs in drug discovery.
Transforming Protein Expression Efficiency
The OmniCHO™ kit stands out in the field of transient expression. It boasts an impressive average antibody production of 2 grams per liter of culture, which would normally require the use of 10 to 20 liters with traditional methods. This remarkable advancement not only enhances productivity significantly but also brings about a cost reduction by a staggering factor of 6 to 30 times for each milligram of protein produced. The kit’s versatility allows it to handle both easily expressed proteins and more challenging ones, including fusion proteins, antigens, and bispecifics. This makes it an essential asset for a diverse array of research projects.
Scalability for Wider Applications
With the OmniCHO™ kit, scalability is a critical advantage. The technology maintains high yield rates from 96-well deep-well plates all the way through to 50-liter bioreactors. Researchers can expect to achieve yields exceeding 1 g/L within just five days, significantly expediting their research timelines and allowing for quicker progression through the drug development pipeline.
A Transformative Approach to Research Economics
Nikhil Goel, CTO of Celltheon, expressed the transformative potential of this new technology, stating, "OmniCHO™ represents a quantum leap in transient protein expression. We are not just improving the process; we are fundamentally changing the economics of preclinical research." This sentiment underscores Celltheon’s commitment to revolutionizing the methodologies employed in life sciences research.
Comprehensive Services to Enhance Efficiency
Alongside the OmniCHO™ kit, Celltheon provides an extensive range of end-to-end services that encompass areas such as gene synthesis, protein production, purification processes, and advanced analytical techniques. This integrated approach ensures that researchers can achieve hundreds of grams of high-quality proteins within a mere four-week timeframe, fostering efficiency and precision in their drug development efforts.
About Celltheon
Celltheon is recognized as a frontrunner in biomanufacturing technology development, with its operations centered in the San Francisco Bay Area. The company prides itself on its advanced platforms that support stable cell line generation, alongside its superior transient expression solutions highlighted by the OmniCHO™ system. Through offering both product purchases and licensing opportunities, Celltheon aims to make biologics drug manufacturing development accessible for businesses of all sizes, from small startups to large biotech firms. With over 200 clients and more than 10,000 projects successfully delivered, Celltheon demonstrates a dedication to excellence and reliability in the biomanufacturing sector.
For those interested in further details about the OmniCHO™ Transient Expression Kit or Celltheon’s services, comprehensive information is available by visiting their official website.
Frequently Asked Questions
What is the OmniCHO™ Transient Expression Kit?
The OmniCHO™ Transient Expression Kit is a cutting-edge solution developed by Celltheon aimed at enhancing productivity and reducing costs in protein expression during preclinical drug development.
How does the OmniCHO™ kit improve efficiency?
This kit allows for higher antibody production yields and reduces the amount of culture needed compared to traditional methods, thereby significantly lowering overall costs.
What types of proteins can be produced using this kit?
The OmniCHO™ kit is versatile enough to express a range of proteins, including challenging fusion proteins, antigens, and bispecifics.
What scale of production can the OmniCHO™ kit handle?
The kit is scalable, effective from small 96-well plates to large 50-liter bioreactors, making it suitable for various research applications.
How does Celltheon support researchers?
Celltheon offers comprehensive services that include gene synthesis, production, purification, and advanced analytics to assist researchers in their drug development processes.
